IR Department expands with ESG practice and new team members

  • New ESG practice bolsters consultancy’s client offering
  • Appointment of Jack McLintock, Annabelle Dick and Anna Cvijetić expand IR Department’s investor and public relations expertise
July 4th, 2023 by IR Department
Read More

Getting started with ESG – what’s it all about?

ESG (environmental, social, and governance) has become a key factor for investors when making investment decisions. As such, incorporating ESG into your investor relations approach is crucial for success.

Our latest blog post explores the benefits of ESG for companies, including attracting socially responsible investors, managing risks, building a positive brand reputation, and ensuring regulatory compliance. We also provide practical tips on how to integrate ESG into your investor relations approach. Read our blog post now and learn how to build a sustainable and responsible business that benefits all stakeholders. 

February 18th, 2023 by Jane Lowe
Read More

IRD Invest - Innovation and change

IRD Invest is a virtual investor conference series hosted by IR Department to showcase emerging companies, and to provide an additional value-add for our investor and client networks.

January 13th, 2022 by Admin
Read More

Surge in growth stocks lifts investor relations activity

2021 has been a record year for the number of initial public offerings (IPOs), with more than 130 on the ASX so far and dozens more anticipated by the end of December. The heightened IPO activity was fuelled by strong investor demand across a broad range of sectors. Led by resources, healthcare and technology stocks, it’s been the biggest global IPO surge in more than 20 years.

October 20th, 2021 by Michael Lovesey
Read More

Atomo Diagnostics (ASX: AT1) presents at IRD Invest

IRD Invest is a virtual investor conference series hosted by IR Department to showcase emerging companies, and to provide an additional value-add for our investor and client networks.

We are all part of a new era. After reaching a low point in mid-2020, the investment landscape has changed dramatically. Companies, like investment markets, are adapting. We want to illustrate how our clients deal with change and provide fresh solutions to assist mitigate the effects of change.

Our third IRD Invest virtual investor conference ran over two days in late September 2021. We heard from a range of ASX listed companies that are innovating by addressing evolving consumer trends and patient needs. 

September 21st, 2021 by Jane Lowe
Read More

What will investors be looking out for this reporting period?

With another financial reporting season upon us, we thought it an opportune time to consider what the investment community will likely be focusing on as they contemplate how best to position their portfolios over the next 6-12 months.

August 12th, 2021 by George Kopsiaftis
Read More

The evolution of social media in crisis communications – Part One: Pre-crisis planning

In the world of issues and crisis management, today’s landscape is dramatically different to that of just a few years ago. Today we are living in a society of digitally enabled, always-on, constantly connected consumers with a multitude of smart devices at their fingertips.

 

July 30th, 2021 by Cherie Hartley
Read More

Biotech 2020

Thanks to all those presenters and investors who made time to attend IRD Invest, IR Department’s virtual investor conference on 29 July 2020.

December 15th, 2020 by Admin
Read More

Tesserent presents at IRD Invest

On 14 October 2020, Tesserent CEO, Julian Challingsworth presented at IR Department’s virtual investor conference, IRD Invest, an event designed to bring investors directly to the CEOs of emerging ASX listed companies.

 

October 26th, 2020 by
Read More

Oventus presents at IRD Invest

On 14 October 2020, Oventus CEO, Dr Chris Hart, presented at IR Department’s virtual investor conference, IRD Invest, an event designed to bring investors directly to the CEOs of emerging ASX listed companies.

 

October 26th, 2020 by
Read More

Technology 2020

October 13th, 2020 by Admin
Read More

Kazia achieves major milestones

Our client, ASX-listed oncology company Kazia Therapeutics Ltd (ASX: KZA; NASDAQ: KZIA, has had a huge few months, including the achievement of significant milestones for lead drug candidate, paxalisib.

October 6th, 2020 by
Read More

All set for your AGM?

We're all starting to think about AGMs (in fact, the IR Department team has already supported clients through a few! As companies are often running virtual AGMs for the first time this year, our friends at IRM have put together some thoughts on the corporate website can be a great tool to support shareholders with understanding how to join and vote. Thanks to the team at IRM for allowing us to share this post.

September 17th, 2020 by The team at IRM
Read More